FibroBiologics Inc [FBLG] stock prices are up 17.65% to $0.4 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The FBLG shares have gain 18.52% over the last week, with a monthly amount glided 54.08%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
FibroBiologics Inc [NASDAQ: FBLG] stock has seen the most recent analyst activity on December 12, 2024, when Rodman & Renshaw initiated its Buy rating and assigned the stock a price target of $12. Previously, H.C. Wainwright started tracking the stock with Buy rating on October 30, 2024, and set its price target to $12. On September 24, 2024, Maxim Group initiated with a Buy rating and assigned a price target of $12 on the stock.
The stock price of FibroBiologics Inc [FBLG] has been fluctuating between $0.22 and $2.00 over the past year. Currently, Wall Street analysts expect the stock to reach $9 within the next 12 months. FibroBiologics Inc [NASDAQ: FBLG] shares were valued at $0.4 at the most recent close of the market. An investor can expect a potential return of 2150.0% based on the average FBLG price forecast.
Analyzing the FBLG fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -2.12, Equity is -12.19 and Total Capital is -8.79. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of56.9.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that FibroBiologics Inc [NASDAQ:FBLG]’s Current Ratio is 0.78. In addition, the Quick Ratio stands at 0.78 and the Cash Ratio stands at 0.72.
Transactions by insiders
Recent insider trading involved GARCIA RUBEN A, General Counsel, that happened on Dec 11 ’25 when 0.14 million shares were purchased. Chief Scientific Officer, Khoja Hamid completed a deal on May 27 ’25 to buy 20000.0 shares.
